The binding of vesicular stomatitis virus (VSV) Many animal viruses bind to specific receptors on the plasma membrane of cells (3, 10, 11, 14) . These receptors are necessary for viral uptake and partially govern the viral host range. The existence of a specific membrane receptor for vesicular stomatitis virus (VSV), a membrane-enveloped, RNA-containing virus, has been questioned for the following reasons: (i) the host range of VSV is extremely broad, extending from insects to mammals; (ii) enzymatic treatment of the cell surface with trypsin or neuraminidase does not inhibit viral infection (24); and (iii) it has not been possible to detect saturable binding of VSV to BHK cells at 37°C (18). Recently, however, we demonstrated that agents that block the receptor-mediated endocytosis of a2-macroglobulin are also able to block the uptake and infectivity of VSV (22). In addition, VSV enters host cells via coated pits and receptosomes (2, 4, 22, 25) , which is the morphological pathway used for many receptorbound ligands (7, 16 1.0 ml of Dulbecco medium with 10%o calf serum, which was buffered with 100 mM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid) buffer (GIBCO Laboratories). 3"S-labeled VSV was added directly in 10l-R amounts and allowed to bind at 4°C for 20 to 22 h, after which the cell monolayers were washed gently three times with ice-cold PBS and then solubilized in 1% Triton X-100. The entire sample was assayed by liquid scintillation. A total of 94% of cellassociated
agents that block the receptor-mediated endocytosis of a2-macroglobulin are also able to block the uptake and infectivity of VSV (22) . In addition, VSV enters host cells via coated pits and receptosomes (2, 4, 22, 25) , which is the morphological pathway used for many receptorbound ligands (7, 16) . These findings suggest that VSV has a cellular receptor. We therefore examined the binding characteristics of VSV to Vero monkey cells at 4°C with a wide range of VSV concentrations. These experiments were performed at 40C to prevent endocytosis (12) and to allow the accurate determination of surface-bound virus. We report evidence that Vero cells display a saturable component for both VSV binding and VSV uptake, implying the existence of a specific cellular receptor.
MATERIALS AND METHODS
Ceil culture. Vero cells were grown in DulbeccoVogt modified Eagle medium supplemented with 10% calf serum. Gentamicin was added to 50 ,ug/ml.
Virus. Large quantities of VSV (strain Indiana) were obtained by infecting 850-cm2 roller bottles of Vero cells with 1 to 5 PFU of VSV per cell. The cultures were kept at 37°C overnight, and the virus was harvested and purified by sucrose gradients (23) . Radiolabeled virus was prepared by infecting Vero cells in 10-cm plastic dishes and changing the medium to methionine-free Eagle minimal essential medium no. These binding studies were repeated three times, and the pooled data were plotted according to the method of Scatchard (21) (Fig. 3) pLg; 100,000 cpm) and increasing amounts of unlabeled VSV were added to confluent Vero monolayers, and the cells were kept at either 4°C for 20 h or 37°C for 1 h. After these incubations, the cultures at 4°C were washed and solubilized, and the amount of bound virus was quantitated. The cultures at 37°C were treated with trypsin-EDTA to remove external VSV (see above), centrifuged, washed, and solubilized, and their content of 35S was measured to determine the amount of internalized VSV. Unlabeled VSV demonstrated a striking parallel in its ability to inhibit VSV binding and uptake (Fig. 4) probably does not directly reflect the number of binding molecules, since VSV is a multivalent ligand, and the stoichiometry of the interactions between the viral G protein and the Vero cell surface is unknown. It is difficult to determine whether the binding to saturable sites is the functionally important route by which VSV enters host cells. Because there is a significant fraction (one-third) of nonsaturable binding even at low virus multiplicities, it is possible that these nonsaturable sites represent a route of infectivity. However, several findings suggest that saturable sites might regulate infectivity. (i) In contrast to the nonsaturable binding and internalization of VSV which occur at enormous VSV multiplicities, functional VSV uptake (uptake which results in viral RNA synthesis) is clearly a saturable process, because high concentrations of UV-inactivated VSV (30 pLg per 35-mm plate) are able to totally inhibit VSV infection (18) . Although the exact site for the saturability of infection has not been determined, the presence of a binding and an uptake component which saturate at similar VSV concentrations (Fig. 4) suggests that this route of entry represents a functional route of VSV infection. (ii) We have reported previously that dansylcadaverine blocks the functional uptake of VSV as well as the internalization of receptorbound a2-macroglobulin (22) . The detection of a saturable binding site or receptor for VSV is consistent with the inhibitory effect of dansylcadaverine on receptor-mediated endocytosis of other ligands (20) .
VSV may enter the host cell by more than one mechanism. For example, there has been some disagreement concerning the relative importance of viropexis (endocytosis of virus) and viral fusion in VSV infection. Early morphological data indicated that VSV enters cells predominantly by viropexis (25) . Other studies suggested that fusion of the virus with plasma membrane represents the major mechanism by which VSV enters and infects cells (8) . Because the studies demonstrating fusion had utilized infection procedures which involved centrifugation of host cells with VSV, it seemed possible that centrifugal forces somehow promoted direct virus-cell fusion. A quantitative electron microscopy study of VSV infection was subsequently performed by Dahlberg in an attempt to resolve this dilemma (2 (4, 22) , it is understandable that this inhibitor would not affect VSV uptake.
When coupled with the morphological, immunological (5), and recent inhibitor studies with lysosomotropic agents (17) , most evidence favors the hypothesis that VSV enters cells via an endocytic mechanism which is mediated by coated pits. After its association with coated pits in the plasma membrane, VSV is transferred into uncoated cytoplasmic vesicles termed receptosomes (4). Similar uncoated endocytic vesicles containing viral particles have been noted previously (9, 15, 25) . After acidification of these vesicles has occurred (27) , VSV could fuse with the vesicle membrane and permit entry of the nucleocapsid into the cytoplasm. This mechanism would be similar to that proposed for Semliki Forest virus (9, 15) except that we believe it more likely that VSV exits from receptosomes than from lysosomes.
VSV binding was not inhibited by treating cells with trypsin. This finding, however, does not eliminate the possibility that the VSV binding site is a protein which is protected by carbohydrates or by tight interaction with lipid. Trypsinization has been previously reported to increase the adsorption of VSV to L cells by a factor of two (24) , and we have also noted a small increase (-25%) in specific binding of VSV after trypsinization. Presumably protease treatment removes surface proteins which sterically prevent access to some VSV binding sites. The physical nature of the saturable VSV binding site is still unknown, but preliminary experiments in this laboratory have shown that it is possible to solubilize the VSV receptor in active form. Whatever its biochemical nature, the receptor will probably be a highly conserved moiety, due to the broad host range of VSV.
